High Tibia Osteotomy
Conditions
Keywords
Tibia osteotomy, Bone healing, Bone filler, Equine Protein, COLLOSS E, TomoFix
Brief summary
The aim of this RCT is to show, that in a patient group receiving COLLOSS E combined with TomoFix for medical open wedge high tibial osteotomy, the onset of bone healing is earlier in time, compared to patients receiving TomoFix without COLLOSS E.
Detailed description
The healing effect should be demonstrated by using MRI pictures during the entire FU's in order to demonstrate the differences if COLLOSS E is applied or not.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult and active patient * Varus malalignment of the leg * Intact lateral joint compartment * Physiological age-appropriate ROM in hip, knee and ankle of affected leg
Exclusion criteria
* BMI\>35 * Drug or alcohol abuse * Known equine protein allergy or immunological anormalities * Immunosuppressive treatment * Systemic or severe local inflammation or infections * History of active malignancy or systemic disease * Impossible to obtain informed consent * Legal incompetence * Pregnant and nursing women * Patients before, during or one year after radio- or chemotherapy * Patients with metal or metal implants near vulnerable structures * Patients with pacemakers or other implanted devices
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of the osteotomy gap volume filled with bone healing tissue as determined on the MRI at 2 and 6 weeks postoperatively | 6 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Bone union | — |
| Complication rate | — |
| Pain asset on the VAS | — |
| Deviation planing angle | — |
| Ligament stability | — |
| Range of motion | — |
| Time to pain free walking | — |
| WOMAC osteoarthritis index | — |
| SF36 Index | — |
| Immuno reaction on equine proteins | — |
Countries
Germany, Switzerland